DNA Database Risks to Privacy and Safety

It was only a matter of time. The recent announcement that GlaxoSmithKline bought a $300 million dollar stake in the leading genomics company 23andMe and now has exclusive rights to 23andMe’s DNA data for drug testing research should come as no surprise to those of you who have been watching the intersection of technology companies […]